Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials
Open Access
- 19 July 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Cardiology Reports
- Vol. 14 (5), 626-634
- https://doi.org/10.1007/s11886-012-0295-5
Abstract
Bioresorbable scaffolds (BRS) represent a novel approach in coronary stent technology. In contrast to the metallic stents, they provide transient scaffolding, thereby safeguarding early vessel patency and acute gain. Subsequently a process of “decomposition” occurs, that results in the complete absorption of the scaffold. This reduces the risk of late complications, allowing the vessel to maintain its integrity and physiological function. This unique ability has attracted interest and nowadays several BRS are available. The aim of this review article is to describe the advances in the field, present the evidence from the preclinical and clinical evaluation of these devices, and provide an overview of the ongoing clinical trials that were designed to examine the effectiveness of BRS in the clinical setting.Keywords
This publication has 22 references indexed in Scilit:
- Late Positive Remodeling and Late Lumen Gain Contribute to Vascular Restoration by a Non-Drug Eluting Bioresorbable ScaffoldCirculation: Cardiovascular Interventions, 2012
- From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?European Heart Journal, 2011
- The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting StentsJournal of the American College of Cardiology, 2011
- Bioresorbable ScaffoldCirculation, 2011
- Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisCirculation, 2010
- Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque MorphologyJournal of the American College of Cardiology, 2008
- Novel bioabsorbable salicylate‐based polymer as a drug‐eluting stent coatingCatheterization and Cardiovascular Interventions, 2008
- Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteriesCatheterization and Cardiovascular Interventions, 2006
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?Heart, 2003